Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
"Big Sam" was spotted letting his hair down in the seaside resort weeks after securing Premier League survival for Sunderland.
Greater Manchester Police visited a property twice on Saturday - finding a body on the second occasion.
163,000 French and 143,000 German soldiers were killed in the 10-month battle in 1916.